Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial
- Michael D. Ezekowitz
- , Charles V. Pollack
- , Paul Sanders
- , Jonathan L. Halperin
- , Judith Spahr
- , Nilo Cater
- , William Petkun
- , Andrei Breazna
- , Paulus Kirchhof
- , Jonas Oldgren
Research output: Contribution to journal › Article › peer-review
30
Scopus
citations